Role of aldosterone in left ventricular hypertrophy among African-American patients with end-stage renal disease on hemodialysis

American Journal of Nephrology

Volumn 27, Issue 2, 2007, Pages 159-163

  Steigerwalt, Susan ^a   Zafar, Abida ^a   Mesiha, Nancy ^a   Gardin, Julius ^a   Provenzano, Robert ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Aldosterone; End stage renal disease; Hemodialysis; Left ventricular hypertrophy

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM; RENIN;

ADULT; AFRICAN AMERICAN; ALDOSTERONE BLOOD LEVEL; BLOOD PRESSURE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RACE; REVIEW; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AFRICAN AMERICANS; AGED; ALDOSTERONE; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 34247164635     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100106     Document Type: Review

References (18)

1. Soylu A, Temizhan A, Duzenli MA, Sokmen G, Koylu O, Telli HH: The influence of aldosterone on the development of left ventricular geometry and hypertrophy in patients with essential hypertension. Jpn Heart J 2004;45:807-821.
2. Delles C, Schmidt BM, Muller HJ, Oehmer S, Klingbeil AU, Schmieder RE: Functional relevance of aldosterone for the determination of left ventricular mass. Am J Cardiol 2003;91:297-301.
3. Rossi GP, Sacchetto A, Visentin P, Canali C, Graniero GR, Palatini P, Pessina AC: Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996;27:1039-1045.
4. Denolle T, Chatellier G, Julien J, Battaglia C, Luo P, Plouin PF: Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma and pheochromocytoma. Am J Hypertens 1993;6:907-913.
5. Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: target-tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583-585.
6. Rossi GP, Di Bello V, Ganzaroli C, Sacchetto A, Cesari M, Bertini A, Giorgi D, Scognamiglio R, Mariani M, Pessina AC: Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002;40:23-33.
7. Harnett JD, Kent GM, Borre PE, Taylor R, Parfrey PS: Risk factors for the development of left ventricular hypertrophy in a prospective cohort of dialysis patients. J Am Soc Nephrol 1994;4:1486-1490.
8. Silverberg J, Barre PE, Pritchard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end stage renal disease. Kidney Int 1989;36:286-290.
9. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 2004;19:1829-1834.
10. Hene RJ, Boer P, Koomans HA, Mees EJ: Plasma aldosterone concentrations in chronic renal disease. Kidney Int 1982;21:98-101.
11. Sato A, Funder J, Saruta T: Involvement of aldosterone in left ventricular hypertrophy of patients with end stage renal failure treated with hemodialysis. Am J Hypertens 1999;12:867-873.
12. Troy BL, Pombo J, Rackley CE: Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 1972;45:602-611.
13. Gottdiener JS, Reda DJ, Materson BJ, Massie BM, Notargiacomo A, Hambutger RJ, Williams DW, Henderson WG: Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol 1994;24:1492-1498.
14. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-618.
15. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-352.
16. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Sabe PS, Vargiu P, Simongini I, Laragh JH: Pattern of left ventricular hypertrophy and geometric remodeling in essential hypertension. Am J Coll Cardiol 1992;19:1550-1558.
17. Vsan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, Murabito JM, Sam F, Colucci WS, Wilson PW: Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study. Hypertension 2004;43:957-962.
18. + homeostasis and ENaC expression in lymphocytes from chronic hemodialysis patients. Kidney Int 2004;66:1647-1653.